EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION

European Medicines Agency approved apixaban use in cardioversion.

Bibliographic Details
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Online Access:https://www.rpcardio.com/jour/article/view/268
Description
Summary:European Medicines Agency approved apixaban use in cardioversion.
ISSN:1819-6446
2225-3653